查詢結果分析
來源資料
頁籤選單縮合
題 名 | 系統性回顧與統合分析方法概述=Overview the Methods of Systematic Review and Meta-analysis |
---|---|
作 者 | 王慧瑜; 葉明功; | 書刊名 | 藥學雜誌 |
卷 期 | 34:1=134 2018.03[民107.03] |
頁 次 | 頁20-26 |
分類號 | 410.3 |
關鍵詞 | 系統性回顧; 統合分析; 品質聲明書; Systematic reviews; Meta-analyses; Quality statements; |
語 文 | 中文(Chinese) |
中文摘要 | 系統性文獻回顧 (systematic reviews, SR) 與統合分析 (meta-analyses, MA) 是一種能 精確可靠地歸納證據,提供證據給臨床醫師及決策者作為判斷風險、利益、及醫療介 入傷害與否的重要工具;其中 SR 能降低影響結論的偏倚因子及作者先入為主的印象 造成的主觀偏見;MA 則是 SR 操作過程中所應用的統計工具,可綜合過去獨立執行 的研究結果,擴充研究文獻的意義,作成客觀性的結論。 自2015年起,每年有30篇藥學領域的這類文章刊登在 PubMed,足見利用 SR-MA 為工具解決臨床問題已逐漸被重視。PRISMA 聲明書是進行 SR 最為重要指引,本文 僅針對其中精華作重點說明,協助有心應用 SR-MA 解決臨床問題的藥師們,依照檢 核表的步驟做有價值的文章發表。 |
英文摘要 | Systematic reviews (SR) and meta-analyses (MA) are accurate and reliable tools for summarizing evidence, to help clinicians and policy makers judge risk, benefit, and medical intervention harm. SR can reduce the conclusions that were affected by study bias, and avoid the prejudice caused by the authors; MA is a statistical tool used in SR process, synthesize various individual studies results to expand the significance of research literature, make an objective conclusions. There are 30 published articles in PubMed annually since 2015, it is clear that SR-MA has been used as a tool to solve clinical problems. PRISMA statement is the most important guideline for SR, this article focus on some important section description, to assist that clinical pharmacist want to application of SR-MA to solve clinical problems, in accordance with the steps of the checklist to do a valuable article published. |
本系統中英文摘要資訊取自各篇刊載內容。